Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Year-long trial finds NAD-boosting supplement fails to improve early Parkinson's symptoms

12

Oct 2026

Year-long trial finds NAD-boosting supplement fails to improve early Parkinson's symptoms

In a phase 3 randomized clinical trial involving 410 people with early Parkinson disease, 52 weeks of nicotinamide riboside supplementation increased blood NAD levels but failed to improve clinical outcomes compared with placebo. Participants receiving the supplement had modestly worse overall disease scores, although the difference was below the threshold generally considered clinically meaningful.

Your favorite song might make a needle prick hurt less

12

Oct 2026

Your favorite song might make a needle prick hurt less

A study of 204 patients undergoing intravenous cannulation before MRI found that those listening to their favorite music reported significantly lower pain scores than patients hearing no music at 30 seconds and two minutes after puncture. Mozart was also associated with lower pain scores among patients with pre-existing pain, while relaxation music showed no significant benefit, although the non-randomized findings require confirmation.

Study finds a surprising downside to having favourite foods

12

Oct 2026

Study finds a surprising downside to having favourite foods

In a study of 279 adults, researchers found that initially reinforcing existing food preferences reduced learning flexibility when associations between foods and outcomes changed. Participants learned positive associations more readily than negative ones, while associations involving disliked foods were more adaptable than those involving liked foods.

Who moves first at night, you or your dog?

12

Oct 2026

Who moves first at night, you or your dog?

Researchers monitored 25 adults and 38 dogs and found no significant association between bedsharing and objectively measured human sleep duration or efficiency, although owners of multiple dogs reported poorer sleep quality in an analysis requiring cautious interpretation. Human and dog movements were positively correlated, with human activity more often preceding canine activity among pairs with identifiable associations, although the study could not determine which species drove the other's movements.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.